HCA Healthcare, Inc. (HCA) stock
HCANYSEServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/303% below fair value
$501.19−10.59 (-2.07%)
Close on Nov 17, 2026Market cap $104.70BP/E 16.6Yield 0.57%
HCA Healthcare revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
HCA Healthcare's revenue for the twelve months ending Sep 30, 2026 was $78.70B, up 5.8% year over year. For fiscal 2025 it was $75.60B, up 7.1% from the year before. Over ten years it grew 7.4% a year on average. The highest annual figure on record is $75.60B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $75.60B | +7.1% |
| FY2024 | Dec 31, 2024 | $70.60B | +8.7% |
| FY2023 | Dec 31, 2023 | $64.97B | +7.9% |
| FY2022 | Dec 31, 2022 | $60.23B | +2.5% |
| FY2021 | Dec 31, 2021 | $58.75B | +14.0% |
| FY2020 | Dec 31, 2020 | $51.53B | +0.4% |
| FY2019 | Dec 31, 2019 | $51.34B | +10.0% |
| FY2018 | Dec 31, 2018 | $46.68B | +7.0% |
| FY2017 | Dec 31, 2017 | $43.61B | +5.1% |
| FY2016 | Dec 31, 2016 | $41.49B | +12.4% |
| FY2014 | Dec 31, 2014 | $36.92B | +8.0% |
| FY2013 | Dec 31, 2013 | $34.18B | +3.5% |
| FY2012 | Dec 31, 2012 | $33.01B | +11.2% |
| FY2011 | Dec 31, 2011 | $29.68B | +5.9% |
| FY2010 | Dec 31, 2010 | $28.04B | +4.7% |
| FY2009 | Dec 31, 2009 | $26.78B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $19.85B | +3.6% |
| Q2 FY2026 | Jun 30, 2026 | $20.23B | +8.7% |
| Q1 FY2026 | Mar 31, 2026 | $19.11B | +4.3% |
| Q4 FY2025 | Dec 31, 2025 | $19.51B | +6.7% |
| Q3 FY2025 | Sep 30, 2025 | $19.16B | +9.6% |
| Q2 FY2025 | Jun 30, 2025 | $18.61B | +6.4% |
| Q1 FY2025 | Mar 31, 2025 | $18.32B | +5.7% |
| Q4 FY2024 | Dec 31, 2024 | $18.29B | +5.7% |
| Q3 FY2024 | Sep 30, 2024 | $17.49B | +7.9% |
| Q2 FY2024 | Jun 30, 2024 | $17.49B | +10.3% |
| Q1 FY2024 | Mar 31, 2024 | $17.34B | +11.2% |
| Q4 FY2023 | Dec 31, 2023 | $17.30B | +11.7% |
| Q3 FY2023 | Sep 30, 2023 | $16.21B | +8.3% |
| Q2 FY2023 | Jun 30, 2023 | $15.86B | +7.0% |
| Q1 FY2023 | Mar 31, 2023 | $15.59B | +4.3% |
| Q4 FY2022 | Dec 31, 2022 | $15.50B | +2.9% |
| Q3 FY2022 | Sep 30, 2022 | $14.97B | -2.0% |
| Q2 FY2022 | Jun 30, 2022 | $14.82B | +2.7% |
| Q1 FY2022 | Mar 31, 2022 | $14.95B | +6.9% |
| Q4 FY2021 | Dec 31, 2021 | $15.06B | +5.4% |
| Q3 FY2021 | Sep 30, 2021 | $15.28B | +14.8% |
| Q2 FY2021 | Jun 30, 2021 | $14.44B | +30.4% |
| Q1 FY2021 | Mar 31, 2021 | $13.98B | +8.7% |
| Q4 FY2020 | Dec 31, 2020 | $14.29B | +5.7% |
| Q3 FY2020 | Sep 30, 2020 | $13.31B | +4.9% |
| Q2 FY2020 | Jun 30, 2020 | $11.07B | -12.2% |
| Q1 FY2020 | Mar 31, 2020 | $12.86B | +2.7% |
| Q4 FY2019 | Dec 31, 2019 | $13.52B | +10.2% |
| Q3 FY2019 | Sep 30, 2019 | $12.69B | +10.9% |
| Q2 FY2019 | Jun 30, 2019 | $12.60B | +9.3% |
| Q1 FY2019 | Mar 31, 2019 | $12.52B | +9.6% |
| Q4 FY2018 | Dec 31, 2018 | $12.27B | +6.2% |
| Q3 FY2018 | Sep 30, 2018 | $11.45B | +7.1% |
| Q2 FY2018 | Jun 30, 2018 | $11.53B | +7.4% |
| Q1 FY2018 | Mar 31, 2018 | $11.42B | +7.5% |
| Q4 FY2017 | Dec 31, 2017 | $11.56B | – |
| Q3 FY2017 | Sep 30, 2017 | $10.70B | – |
| Q2 FY2017 | Jun 30, 2017 | $10.73B | – |
| Q1 FY2017 | Mar 31, 2017 | $10.62B | – |
See a number that looks wrong?